Sherbrooke Park Advisers’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-10,379
Closed -$133K – 692
2025
Q1
$133K Buy
+10,379
New +$167K 0.06% 480
2024
Q4
– Sell
-19,737
Closed -$451K – 1038
2024
Q3
$451K Sell
19,737
-8,440
-30% -$191K 0.1% 351
2024
Q2
$647K Buy
28,177
+21,750
+338% +$670K 0.11% 303
2024
Q1
$255K Buy
6,427
+947
+17% +$37.5K 0.05% 632
2023
Q4
$217K Buy
+5,480
New +$229K 0.1% 315

Other funds holding NRC

Sherbrooke Park Advisers's NRC Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of NRC Health Common Stock (NRC) in Q2 2025, closing a stake of 10,379 shares — an estimated $133K sold.

Sherbrooke Park Advisers first reported a position in NRC in Q4 2023 and held it in 5 quarters. The position peaked at $647K in Q2 2024. 126 funds tracked by Wall St. Rank hold NRC as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining NRC Health Common Stock position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 10,379 NRC Health Common Stock shares in Q2 2025, an estimated $133K.
  • Sherbrooke Park Advisers first reported a position in NRC Health Common Stock in Q4 2023 and held it in 5 quarters.
  • Sherbrooke Park Advisers's NRC Health Common Stock position peaked at $647K in Q2 2024.
  • 126 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.